Most Popular
-
1
Ador CEO denies allegations, accuses Hybe of mistreating NewJeans
-
2
[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'
-
3
Nicaragua shuts down Seoul embassy
-
4
Medical reform committee kicks off despite boycott from doctors
-
5
10-man S. Korea lose to Indonesia to miss out on Paris Olympic football qualification
-
6
Rocket engine expert, ex-NASA exec to lead Korea's new space agency
-
7
SK hynix pledges W20tr to ramp up DRAM production at home
-
8
DP leader says he will meet Yoon without conditions
-
9
Over 9,000 hotline calls made by stalking victims in 2023
-
10
[Hello India] Hyundai Motor vows to boost 'clean mobility' in India
-
Hyundai Construction Equipment to develop small-sized forklifts
South Korean construction machinery maker Hyundai Construction Equipment Co. on Tuesday said it will develop small-sized forklifts to be powered by hydrogen fuel cells. The subsidiary of Hyundai Genuine Co. will team up with S-Fuelcell Co., a local hydrogen fuel cell maker, to commercialize the 1-3 ton forklifts by 2023, it said. Hyundai Construction Equipment also said it developed 5-ton hydrogen fuel cell powered forklifts in 2020 in cooperation with Hyundai Mobis Co., South Korea's biggest
Aug. 17, 2021
-
LG Display to invest W3.3 tr to expand OLED capacity
LG Display Co., a major display panel maker in South Korea, said Tuesday it will invest 3.3 trillion won ($2.8 billion) to expand its medium-and-small sized OLED display production capacity. The company said the investment, which will be made through March 2024, will be used in OLED facilities in South Korea that manufacture sixth-generation (1,500mm x 1,850mm) substrates. LG Display is the world's sole supplier of large-size OLED panels for TVs, but its competitiveness in the medium-and-
Aug. 17, 2021
-
Samsung leads Q2 curved monitor market
Samsung Electronics Co. was the world's largest curved monitor vendor in the second quarter of the year, a report showed Tuesday, although its shipments decreased sharply from a quarter earlier. Samsung had a market share of 32 percent in the April-June period after shipping 1.09 million curved monitors, according to market researcher TrendForce. AOC/Philips, owned by TPV Technology Ltd., was the runner-up with a 12 percent market share with 410,000 units. Micro-Star International Co. and Dell
Aug. 17, 2021
-
Samsung Display's low-power OLED panels inside latest foldable phone
Samsung Display’s new power-saving OLED display panels can be found inside Samsung Electronics’ latest smartphone, the Galaxy Z Fold3, according to the display maker on Monday. The new displays, developed with what the company brands as Eco2 OLED technology, cut power consumption by up to 25 percent, it added. The firm has made a number of efforts to debut low-power OLED panels, with a focus on polarizers. Polarizers are key components in a panel that eliminate reflections from e
Aug. 16, 2021
-
[Gadget Review] Samsung foldables deserve credit for upgrades
Samsung Electronics’ two latest foldable smartphones, Galaxy Z Fold3 and Z Flip3, didn’t seem to have the “wow” factor when first unveiled, but at a closer look, they do deserve some praise. As a user of Z Flip, with a husband who also owns the Galaxy Z Fold, I personally had expectations for new editions of the foldable devices, hoping they would be “more comfortable” to use in daily life. As I had hoped, Galaxy Z Fold3 became slightly thinner and lighte
Aug. 16, 2021
-
Kakao opens blockchain units in Singapore, eyes expansion overseas
Kakao Group, which operates messenger app KakaoTalk, has established two new blockchain entities in Singapore in an effort to expand its blockchain platform abroad and chase after its biggest competitor, Naver. According to local media reports Monday, Kakao recently founded the nonprofit Klaytn Foundation and global accelerator unit Krust in the city-state. With the two at the forefront, the South Korean internet giant will pursue the globalization of its public blockchain project, Klaytn,
Aug. 16, 2021
-
[Anniversary Special] S. Korea’s pharmaceutical industry grows through COVID-19, prepares for post-pandemic future
The pandemic has opened up a window of opportunity for South Korean pharmaceutical and biotech companies to advance to the global stage. Several local players posted strong earnings by exporting self-developed test kits to foreign countries and secured contract manufacturing deals for COVID-19 vaccines. As a result, the number of pharmaceutical and biotech firms with sales exceeding 1 trillion won ($860.2 million) has increased to nine in 2020 from six a year earlier. Contract development
Aug. 14, 2021
-
Samsung SDI may build an EV battery plant in Illinois : news reports
Samsung SDI may build a battery plant in central Illinois, according to a report by Reuters on Friday. The news came after Illinois Sen. Dick Durbin said in a press conference that there were discussions to bring in a “major Samsung battery facility” during their meeting with South Korean delegations this week. While the decision has not been finalized, said Durbin, the facility will possibly be next to electric-vehicle start-up Rivian, which said in April it would source EV batt
Aug. 13, 2021
-
Celltrion's Q2 operating profit falls 10.2% on-year
South Korean pharmaceutical giant Celltrion on Friday said the company’s operating profit fell 10.2 percent in the second quarter through an earnings report. The firm’s operating profit stood at 163.2 billion won during the April-June period, down 10.2 percent from the same period last year. Its sales inched up 0.7 percent to 431.8 billion won. The company said its second-quarter revenue went slightly up, backed by increased overseas sales of the company’s infliximab bios
Aug. 13, 2021
-
S. Korea signs contract with Pfizer to buy 30m COVID-19 vaccine doses
South Korea has signed a contract with US pharmaceutical giant Pfizer to purchase 30 million doses of the drugmaker’s COVID-19 vaccine for use in 2022, the Korea Disease Control and Prevention Agency said Friday. The deal is part of Seoul’s plan to procure 50 million vaccine booster shots for the country’s population of 52 million, according to KDCA Director Jeong Eun-kyeong. Pfizer’s first batch will ship out in the first quarter of next year, the KDCA added. Under t
Aug. 13, 2021
-
Samsung Bioepis sees 30% jump in biosimilar sales in H1
South Korean drugmaker Samsung Bioepis said Friday that global sales of five major biosimilar products increased 30 percent on-year in the first half of this year. Sales of the five biosimilar products during the first half reached $166 million, from $128 million from the same period a year earlier, according to an earnings report of its global pharmaceutical partner Organon International, a spinoff of US-based Merck. The five products are etanercept, infliximab, adalimumab, trastuzumab and
Aug. 13, 2021
-
[From the Scene] Hundreds gather to watch Lee leave jail
UIWANG, Gyeonggi Province -- Lee Jae-yong, de facto leader of South Korea’s largest conglomerate Samsung Electronics, has been released on parole Friday. At 10 a.m. on Friday, Lee walked free from the Seoul Detention Center in Uiwang, Gyeonggi Province after being jailed for bribery. Around 300 citizens and global media thronged the area in the hours before Lee’s release. In front of the detention center’s gate, members of conservative civic groups held up placards and ba
Aug. 13, 2021
-
Celltrion’s COVID-19 treatment wins emergency use authorization in Brazil
South Korean pharmaceutical giant Celltrion said Thursday that the company’s COVID-19 antibody treatment has won an emergency approval from the Brazilian government. According to Celltrion, the Brazilian Health Regulatory Agency gave emergency use authorization to the company’s COVID-19 treatment Regkirona, or CT-P59. The approval was based on results from all three phases of the clinical study of COVID-19 treatment Rekirona, as well as preclinical studies that suggest the effic
Aug. 12, 2021
-
GC Pharma reports positive clinical trial results of immunoglobulin product
GC Pharma on Thursday reported positive top-line results from the phase 3 clinical trial of its immunoglobulin product GC5107. The clinical study results have been published in the peer-reviewed journal Frontiers in Immunology, the company said. The phase 3 study was conducted on 49 patients who were diagnosed with primary immunodeficiency. The patients aged between 3-70 received infusions of GC5107 doses every 21 or 28 days for 12 months at 17 medical institutions in the US and Canada. Th
Aug. 12, 2021
-
ICT exports reach fresh high in July
South Korea's exports of information and communication technology (ICT) products hit a record high in July, data showed Wednesday, rising for the 14th consecutive month thanks to global demand for chips and displays. Outbound shipments of ICT products stood at $19.5 billion last month, up 30.2 percent from a year earlier, according to the data from the Ministry of Science and ICT. The figure marks a fresh high for July after reaching $18.5 billion in 2018. Imports reached $11.32 billion last mon
Aug. 12, 2021
-
Samsung Electro-Mechanics develops 2 MLCCs for self-driving vehicles
Samsung Electro-Mechanics, a component supplier of Samsung Electronics, said Thursday it has developed two key multi-layer ceramic capacitors for autonomous driving systems. One is the smaller than any MLCCs currently available for advanced driver assist systems, or ADAS, measuring 0.6 millimeters in length and 0.3 mm across, the firm said. The other boasts storage of 47 microfarads. The company expects the new products to be widely used for self-driving cars in the foreseeable future. T
Aug. 12, 2021
-
Samsung’s new foldables more practical, but lack ‘wow’
Samsung Electronics is making a big bet on the fate of its smartphone business by replenishing its flagship lineup for the remaining 2021 with cheaper, more durable foldable smartphones. The Korean tech giant presented the Galaxy Z Fold3 and Galaxy Z Flip3, two models of the Galaxy Watch4 and the wireless ear buds Galaxy Buds2, in a Galaxy Unpacked show that was live-streamed from Seoul at 11 p.m. Wednesday. The third-generation models of the inwardly folding Z Fold and clamshell-type Z Fl
Aug. 11, 2021
-
CJ OliveNetworks builds first software-based network using public cloud in Germany
CJ OliveNetworks, an IT solution provider of CJ Group, said Wednesday that the company succeeded in establishing a network using public cloud and software-based WAN in Germany in what it said was an industry first. Known as SD-WAN, the software-defined network enables establishing virtual over-lay networks by connecting with a variety of networks like MPLS, internet and 4G, providing customers with flexibility and efficiency. The CJ affiliate adopted SD-WAN to the public cloud systems used
Aug. 11, 2021
-
Korea’s PC market expands but growth pace cools in Q2
South Korea’s personal computer market continued to expand in the April-June period of 2021, helped by a solid demand due to the prolonged pandemic, but there were signs that the growth rate would taper off, latest industry data showed. Domestic PC shipments came in at 1.5 million units in the second quarter, up 3.1 percent from a year ago, according to the data from market researcher IDC Korea. The second-quarter PC shipment volume marked a sharp drop from 1.89 million units in the Ja
Aug. 11, 2021
-
Celltrion strives to increase accessibility of self-developed COVID-19 treatment
South Korean pharmaceutical giant Celltrion is pushing for a broader use of its COVID-19 treament, Regkirona, both here and abroad. Presently, Regkirona, or CT-P59, is allowed to be used on patients with severe symptoms or high risk groups with mild symptoms only. The company said Wednesday that it has asked the Ministry of Food and Drug Safety for permission to use on COVID-19 patients aged over 12, with mild or severe symptoms. Celltrion said it has filed clinical data from its phase 3 cli
Aug. 11, 2021